maxidex sterile ophthalmic ointment 0.1%
novartis (singapore) pte ltd - dexamethasone - ointment - 0.1% with 3% overage - dexamethasone 0.1%
maxidex ointment
novartis pharmaceuticals canada inc - dexamethasone - ointment - 0.1% - dexamethasone 0.1% - corticosteroids
tobradex eye ointment
novartis corporation (malaysia) sdn. bhd. - dexamethasone; tobramycin -
maxidex 0.1 %w/v eye drops suspension
alcon laboratories (uk) ltd - dexamethasone - eye drops suspension - 0.1 %w/v - corticosteroids, plain
maxidex ophthalmic suspension
novartis corporation (malaysia) sdn. bhd. - dexamethasone -
maxidex- dexamethasone suspension/ drops
alcon laboratories, inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - suspension/ drops - 1 mg in 1 ml - steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctuate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. contraindicated in epithelial herpes simplex (dendritic keratitis), vaccinia, varicella, and most other viral diseases of the cornea and conjunctiva; tuberculosis of the eye; fungal disease of ocular structures; and in those persons who have shown hypersensitivity to any component of this preparation.
maxidex- dexamethasone suspension
alcon laboratories, inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. contraindicated in acute, untreated bacterial infections; mycobacterial ocular infections; epithelial herpes simplex (dendritic keratitis); vaccinia, varicella, and most other viral diseases of the cornea and conjunctiva; fungal disease of ocular structures; and in those persons who have shown hypersensitivity to any component of this preparation.
maxidex- dexamethasone suspension/ drops
novartis pharmaceuticals corporation - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. contraindicated in acute, untreated bacterial infections; mycobacterial ocular infections; epithelial herpes simplex (dendritic keratitis); vaccinia, varicella, and most other viral diseases of the cornea and conjunctiva; fungal disease of ocular structures; and in those persons who have shown hypersensitivity to any component of this preparation.
maxidex eye drops 0.1%
dexamethasone -
maxidex sterile ophthalmic suspension 0.1%
novartis (singapore) pte ltd - dexamethasone - solution - 0.10% - dexamethasone 0.1%